Myanmar Says Tolerance Growing To Artemisinin Malaria Drug
This article was originally published in PharmAsia News
Executive SummaryMyanmar reports an increasing tolerance to the key drug for treating malaria, artemisinin, a situation the World Health Organization fears could become a regional problem
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.